Navigation Links
Vasomedical Announces Financial Results for the First Quarter of 2013
Date:5/15/2013

se in commission revenue recognized in the first quarter of 2013 to $6.0 million, compared to $4.1 million for the same period in 2012. The increase in commission revenue is a result of higher volume of equipment delivered to customers during the first quarter of 2013 compared to the same period of 2012.

Gross profit for the first quarter of 2013 was $5.1 million, for a gross margin of 69.4%, compared to a gross profit of $4.2 million, for a gross margin of 69.2%, for the first quarter of 2012.

Selling, general and administrative (SG&A) expenses for the first quarter of 2013 were $5.6 million compared to $5.3 million for the same period last year. The increase in SG&A expense resulted primarily from costs in the Sales Representation segment of approximately $238,000 associated with the extension of the GEHC contract. This cost increase is a non-recurring charge that will be completed in the second quarter 2013.

Net loss for the three months ended March 31, 2013 was $0.7 million, or $0.00 per basic and diluted common share, compared to a net loss of $1.3 million, or $0.01 per basic and diluted common share, for the three months ended March 31, 2012. 

In April 2013, the Company's Board of Directors authorized a share repurchase program of up to $1.5 million of the Company's common stock, representing approximately 5% of the total outstanding shares of Vasomedical common stock as of April 30, 2013.  The repurchase program is being actively implemented in compliance with relevant SEC guidelines; 367,427 shares have been bought back through Friday, May 10, 2013.

Conference Call Information The Company will host a conference call tomorrow, Thursday, May 16th at 10:00 a.m. ET. To dial into the conference call, please dial 1-866-393-1344 from the U.S. or 1-631-291-4669 internationally. All dial-in participants must use the following code to access the call: 57513438. Please call at least five minutes before
'/>"/>

SOURCE Vasomedical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vasomedical to Report First Quarter 2013 Results on May 15, 2013
2. Randy Hill Appointed to Vasomedical Board of Directors
3. Vasomedical Announces Share Repurchase Program of up to $1.5 Million in Common Stock
4. Vasomedical Announces Financial Results for the Fourth Quarter and Year Ended 2012
5. Vasomedical to Report Fourth Quarter and Year End 2012 Results on April 1, 2013
6. Vasomedical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
7. Vasomedical, Inc. to Present Live Webcast at RetailInvestorConferences.com on February 7th
8. The International EECP Therapists Association and Vasomedical Announce Second Annual EECP Therapy Week
9. Vasomedical Common Stock Commences Trading on the OTCBB
10. Vasomedical Announces Financial Results for the Third Quarter of 2012
11. Vasomedical Named on Deloittes 2012 Technology Fast 500 List
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015  Pomerantz LLP is ... Inc. ("Vitae" or the "Company") (NASDAQ: VTAE ... S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ... and certain of its officers and/or directors have violated ... of 1934.  On February 27, 2015, ...
(Date:2/27/2015)...  Pharmacyclics, Inc. (NASDAQ: PCYC ) ... in the Proceedings of the National Academy ... when ibrutinib (IMBRUVICA ® ) was combined with ... tumor growth was enhanced suggesting a greater response ... and solid tumors with the combination. IMBRUVICA is ...
(Date:2/27/2015)...  Acsis Inc., the market leader for supply chain ... John DiPalo , Acsis, Chief Strategy Officer, has ... Executive 2015 Provider Pro to Know. The award ... help prepare their companies, and customers, supply chains for ... list of Provider Pros to Know is featured in ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 4In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 5In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 6In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 7In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 8In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 9Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2
... AcelRx Pharmaceuticals, Inc. announced today that results ... of its oral transmucosal NanoTab(TM) formulation of sufentanil ... the upcoming American Society of Anesthesiologists Annual Meeting ... Officer of AcelRx, will present in the following ...
... Oct. 15 Azopharma Product Development Group, LLC, ... services and PharmaNet Development Group, Inc., a leading ... biotechnology, generic drug and medical device companies, are ... development and co-promotion alliance to leverage complementary services, ...
Cached Medicine Technology:Azopharma and PharmaNet Development Group Enter Preclinical Strategic Alliance 2
(Date:2/27/2015)... Over 440,000 patients die annually as a result of ... jet airplanes crashing each day. Now more than ever before, ... to do all they can to stay safe. , Through ... U.S. Surgeon General, discusses the importance of safer hospitals. “It’s ... safety issues to ensure that all our patients are in ...
(Date:2/27/2015)... 27, 2015 Muscular Dystrophy Association ... Engineering at Duke University, recently announced a potentially ... young men with Duchenne muscular dystrophy (DMD). The ... and Gersbach will discuss their implications at MDA's ... in Washington, D.C. , Background: Gersbach and ...
(Date:2/27/2015)... Over 440,000 patients die each year as a ... educate readers on how they can take control of their ... a guide to educate and inspire readers to learn more ... safe with tips on topics ranging from hospital to anesthesia ... the print publication. He recently spoke to Mediaplanet ...
(Date:2/27/2015)... 27, 2015 With cases of head ... concerned parents look to school administrations to help prevent the ... head lice is a common parasite that passes easily among ... causing parents and teachers significant distress. , The answer ... at the school. This would allow parents and teachers to ...
(Date:2/27/2015)... Schenectady, New York (PRWEB) February 27, 2015 ... has been named one of the Best Companies to ... , “Transfinder recognizes the importance of creating a great ... a demanding – yet professionally fulfilling – environment. There’s ... doing great work together,” said Antonio Civitella, president and ...
Breaking Medicine News(10 mins):Health News:Dr. Richard Carmona, the 17th U.S. Surgeon General, and IntelliCentrics Raise Awareness in Mediaplanet’s “Patient Safety” Campaign 2Health News:Statement: New MDA-Funded Genetic Therapy Technique Targets DMD 2Health News:Safe and Sound: Improving Patient Outcomes through Mediaplanet’s “Patient Safety” Campaign 2Health News:South Florida Parents Put Pressure on Schools to Perform Lice Screenings to Prevent Spread of Lice According to One Miami Lice Removal Company Called Lice Troopers 2Health News:Transfinder Named a Best Company to Work for in New York State 2
... simple guidelines can help , TUESDAY, May 25 (HealthDay News) ... decade ago, she scoured the Internet looking for treatments. , ... said Anderson, now community scientific liaison at Kennedy Krieger Institute,s ... nonsense. It was hope. People will try all sorts of ...
... ... to get their important messages across to employees, snap out of it! SnapComms ... , ... May 20, 2010 -- Toronto-based Hoppen Group Incorporated, one of Canada,s top internal communications ...
... ... grill tips and secrets with Sam,s Club - ensuring that you turn out perfectly grilled ... Bentonville, ... a great Memorial Day cookout? Pitmaster, barbecue champion and cookbook author Troy Black shares his ...
... , ... , a leading provider of interoperable workflow solutions, announced today the availability of a ... transitions and close information gaps between systems, departments and facilities through collaboration and clinical ... ...
... ... of its new online health book category with The Myth About Stress by Michael ... , ... AZ (PRWEB) -- Nutri-Health Supplements, LLC, a leader in direct-to-consumer probiotic supplements, announces the ...
... Orders for OPA Digest May ... (PRWEB) -- A ... Mr. William Bode, Esq., managing partner of the law firm of Bode & Grenier, LLP ... starting today. The Digest was originally published in 2004 and contains a summary, organized by ...
Cached Medicine News:Health News:As Autism Web Sites Boom, Experts Urge Caution 2Health News:As Autism Web Sites Boom, Experts Urge Caution 3Health News:The Hoppen Group Announces Partnership with SnapComms Tools 2Health News:The Hoppen Group Announces Partnership with SnapComms Tools 3Health News:Memorial Day Grilling: "How-to" Secrets and Tips from Barbecue Champ Troy Black and Sam's Club For The Perfect Memorial Day Cookout 2Health News:Expert Insights on Health Data Sharing, Collaboration, Quality and Meaningful Use Featured in Latest Carefx Position Paper 2Health News:Expert Insights on Health Data Sharing, Collaboration, Quality and Meaningful Use Featured in Latest Carefx Position Paper 3Health News:New Book Says Good Stress and Probiotics can Change Your Life 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: